What EUROPLASMA does

Europlasma GmbH is a privately held Austrian plasma collection company headquartered in Vienna, founded in 1985 and operating for nearly 40 years. The company runs 10 physical plasma donation centers across Austria — Vienna (9th and 21st districts), St. Pölten, Retz, Hainburg an der Donau, Seiersberg, Leoben, Oberwart, and Kittsee — with an 11th center scheduled to open in Krems in early 2026. Its core service is plasmapheresis: an automated blood-separation process lasting 30–45 minutes in which plasma is collected and other blood components (red blood cells, platelets) are returned to the donor. Donors receive €40 per donation as expense allowance and may donate up to 50 times per year, with a mandatory 72-hour interval between sessions.

The company's product surface extends beyond plasma collection to include a dedicated iOS/Android mobile app for appointment booking, donation history, and health tracking; a web-based self-service booking system (termine.europlasma.at); a Buddy referral program paying €30 per recruited donor; regular health-monitoring services (blood pressure, pulse, hemoglobin, infection testing every donation, with full medical exams every four months); and platelet donation at the Vienna 9 center. Plasma collected is supplied to pharmaceutical partner LFB (Laboratoire Français du Fractionnement et des Biotechnologies), a French biopharmaceutical group with 2,000+ employees, for fractionation into medicines used in immunology, hemostasis, and intensive-care applications.

Europlasma operates a direct-to-consumer go-to-market: healthy adults aged 18–60 (50–150 kg body weight, Austria or neighboring-country residency) book appointments via website, mobile app, or phone, undergo an initial medical examination, and become part of a recurring donor community. The company is privately held with 251–500 employees, no institutional investors disclosed, and operates as an independent entity following prior affiliation with the LFB group. No public revenue figures are available; the company is part of an LFB-affiliated network of 26 donation centers across Austria, Germany, and the Czech Republic.

Name

EUROPLASMA

Legal name

Europlasma GmbH

Website

https://europlasma.at

Company type

Private

Founded year

1985

Operating status

Operating

Headcount range

251–500 employees

Short description

Europlasma GmbH is an Austrian plasma collection company, founded in 1985, operating 10 donation centers across Austria (with Krems opening in 2026). It collects source plasma from individual donors and supplies it to pharmaceutical partner LFB for fractionation into immunology, hemostasis, and intensive-care medicines.

Ownership category

akta.pro rank

Product category

Plasma Collection Services

NAICS

Blood and Organ Banks (621991)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Plasma Collection & Donor Services (Plasmapheresis Centers) (HLAIAHAH)

akta.pro secondary industry

Plasma-Derived & Blood Products Distributors (HLAIAJAJ)

Keywords

• Plasma donation services
• Blood plasma collection
• Plasmapheresis services
• Plasma supply pharmaceutical
• Donor center operations

Headquarters

HQ city

Vienna

HQ country

Austria

HQ region

Europe

Offices10 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Supply Chain, Technology or R&D

Revenue model

1. Plasma Collection and Supply: Europlasma collects plasma from donors at its collection centers and supplies it to pharmaceutical partners for processing into life-saving medications. Donors receive €40 per donation as compensation, with maximum 50 donations per year per donor.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

Europlasma operates 10 physical plasma donation centers across Austria where healthy adult donors undergo plasmapheresis — a 30–45 minute automated blood separation process that collects plasma and returns other blood components to the donor. Collected plasma is supplied to pharmaceutical partner LFB Group for fractionation into life-saving medications for immunology, hemostasis, and intensive medicine. Donors receive €40 compensation per donation and may donate up to 50 times per year.

Product overview

EUROPLASMA is a plasma donation company operating 10 plasma donation centers across Austria (with Krems opening in early 2026), with a total of 26 centers across Austria, Germany, and Czech Republic. The core offering is plasma collection services for manufacturing life-saving medications. The product portfolio includes: (1) Plasma Donation Services at 10 Austrian centers, (2) Europlasma Mobile Application for iOS/Android enabling appointment management and health tracking, (3) Online Appointment Booking System (termine.europlasma.at), (4) Buddy Program for donor referrals, (5) Health Check Services including pre-donation screening and quarterly medical examinations, and (6) Platelet Donation at the Vienna 9 center. Plasma collected is processed by pharmaceutical partner LFB into medications for immunology, hemostasis, and intensive medicine applications.

Differentiator

Problem solved

Functional benefit

Products and services

• Plasma Donation Services

Quantifiable outcome

• Donors can contribute to producing life-saving medications for patients with immune deficiencies, enzyme deficiencies, hemophilia, severe injuries, burns, and surgeries.
• +2 more outcomes

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• LFB (Laboratoire Français du Fractionnement et des Biotechnologies)coreStrategic or Co-development PartnerLFB is a French biopharmaceutical company with over 2,000 employees in Europe. Europlasma, as part of the LFB Group, collects plasma that LFB processes into life-saving medications. LFB develops, manufactures, and markets plasma-based medicines for patients with severe and often rare diseases in three main areas: Immunology (immune deficiency treatment), Hemostasis (blood clotting disorders), and Intensive Medicine (life-saving emergency therapies). This partnership ensures plasma collected by Europlasma is processed under the highest quality conditions.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Kedrion Biopharma: Italian plasma fractionator that collects and processes plasma for therapeutic use, with European center operations. Comparable in being a vertically integrated plasma collector and fractionator with a compensated-donor model.
• Grifols: Spanish global plasma therapeutics major that operates a large plasma donation center network alongside its own fractionation and diagnostic businesses. Directly comparable in business model, donor compensation economics, and integrated biopharma structure.
• Octapharma: Swiss-headquartered plasma fractionator that also operates its own plasma collection centers in Europe and the US. Comparable in that it sits at the same intersection of donor collection and plasma-derived medicine manufacturing.
• CSL Plasma: One of the world's largest plasma collection networks, operating hundreds of centers globally including in Europe. Directly comparable to Europlasma in donor compensation model, plasmapheresis process, and pharmaceutical off-take to a vertically integrated fractionator (CSL Behring).
• Biotest (Grifols subsidiary): German plasma-derived biotherapeutics company with plasma collection operations in the DACH region. Directly comparable given overlapping geography (Germany/Czech Republic) and similar donor-compensation center model.

Broad incumbents

• BioLife Plasma Services: US-focused plasma collection network owned by Takeda. Comparable as a major paid-donor plasma center operator, but operates predominantly in North America rather than DACH.
• Takeda Pharmaceutical Company: Global biopharmaceutical company whose BioLife Plasma Services subsidiary operates the largest US plasma center network and which markets plasma-derived therapies (e.g., IG, albumin). Comparable as a vertically integrated player combining large-scale collection with fractionation and commercialization.

Regional players

• Haema (in Germany): German plasma donation center operator. Comparable as a regional plasma collection competitor operating in DACH geography, with the same donor-compensation and plasmapheresis process.
• Sanquin Plasma Products: Dutch blood supply foundation with plasma collection operations. Comparable as a European plasma collector, though organized under a nonprofit model rather than purely compensated donor economics.

Emerging players

• PlasmaCare (UK): Smaller plasma donation operator in the UK. Comparable as an emerging European paid-donor plasma center network with the same regulatory and supply-chain dynamics, though at smaller scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• Facebookfacebook.com/europlasma.oesterreich
• Instagraminstagram.com/europlasma
• YouTubeyoutube.com/europlasma
• TikToktiktok.com/@europlasma
• LinkedInlinkedin.com/company/europlasma-gmbh

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EUROPLASMA